Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...

Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid weakening demand for its COVID-19 vaccine. The ...

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

Darwin's theory of natural selection provides an explanation for why organisms develop traits that help them survive and reproduce.

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Holmes was first seen with Evans at Burning Man festival in 2018, per the New York Times. Evans is graduate of the Massachusetts Institute of Technology. His father, Bill Evans, owns and operates ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

North Carolina life sciences companies, startups and academic institutions are tackling some of the world's greatest ...

Global net sales of EPKINLY/TEPKINLY were USD 281 million in 2024. Net product sales in the U.S. and Japan by Genmab were DKK 1,743 million in 2024 compared to DKK 421 million in 2023. EPKINLY was ...